These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33428652)

  • 1. Prevalence and correlates of metabolic syndrome and its components in adults with psychotic disorders in Eldoret, Kenya.
    Kwobah E; Koen N; Mwangi A; Atwoli L; Stein DJ
    PLoS One; 2021; 16(1):e0245086. PubMed ID: 33428652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of lifestyle cardiovascular risk factors and estimated framingham 10-year risk scores of adults with psychotic disorders compared to controls at a referral hospital in Eldoret, Kenya.
    Kwobah E; Koen N; Mwangi A; Atwoli L; Stein DJ
    BMC Psychiatry; 2023 Dec; 23(1):909. PubMed ID: 38053103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION AMONG TYPE 2 DIABETIC PATIENTS AT MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA.
    Ndege BW; Diero LO; Owiti MO; Anjichi G; Siika AM
    East Afr Med J; 2014 Aug; 91(8):253-60. PubMed ID: 26862649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and its components among university students in Kenya.
    Mbugua SM; Kimani ST; Munyoki G
    BMC Public Health; 2017 Nov; 17(1):909. PubMed ID: 29183300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey.
    Suvisaari JM; Saarni SI; Perälä J; Suvisaari JV; Härkänen T; Lönnqvist J; Reunanen A
    J Clin Psychiatry; 2007 Jul; 68(7):1045-55. PubMed ID: 17685741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotic disorder is an independent risk factor for increased fasting glucose and waist circumference.
    Osby U; Olsson E; Edman G; Hilding A; Eriksson SV; Ostenson CG
    Nord J Psychiatry; 2014 May; 68(4):251-8. PubMed ID: 23795858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loneliness in psychotic illness and its association with cardiometabolic disorders.
    Badcock JC; Mackinnon A; Waterreus A; Watts GF; Castle D; McGrath JJ; Morgan VA
    Schizophr Res; 2019 Feb; 204():90-95. PubMed ID: 30243852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and gallstone disease.
    Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
    World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis.
    Galletly CA; Foley DL; Waterreus A; Watts GF; Castle DJ; McGrath JJ; Mackinnon A; Morgan VA
    Aust N Z J Psychiatry; 2012 Aug; 46(8):753-61. PubMed ID: 22761397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia.
    Tadewos A; Egeno T; Amsalu A
    BMC Cardiovasc Disord; 2017 Aug; 17(1):218. PubMed ID: 28789613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender Differences in the Pattern of Socio-Demographics Relevant to Metabolic Syndrome Among Kenyan Adults with Central Obesity at a Mission Hospital in Nairobi, Kenya.
    Okube OT; Kimani ST; Mirie W
    High Blood Press Cardiovasc Prev; 2020 Feb; 27(1):61-82. PubMed ID: 31981085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study.
    Meyer JM; Pandina G; Bossie CA; Turkoz I; Greenspan A
    Clin Ther; 2005 Dec; 27(12):1930-41. PubMed ID: 16507379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome among an urban population in Kenya.
    Kaduka LU; Kombe Y; Kenya E; Kuria E; Bore JK; Bukania ZN; Mwangi M
    Diabetes Care; 2012 Apr; 35(4):887-93. PubMed ID: 22374643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya.
    Osoti A; Temu TM; Kirui N; Ngetich EK; Kamano JH; Page S; Farquhar C; Bloomfield GS
    AIDS Patient Care STDS; 2018 Jun; 32(6):215-222. PubMed ID: 29851503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of metabolic alterations in Latin American patients at initial stages of psychosis.
    Iruretagoyena B; Castañeda CP; Undurraga J; Nachar R; Mena C; Gallardo C; Crossley NA; Gonzalez-Valderrama A
    Early Interv Psychiatry; 2019 Dec; 13(6):1382-1388. PubMed ID: 30644164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: results from the CLAMORS study.
    Bobes J; Arango C; Aranda P; Carmena R; Garcia-Garcia M; Rejas J;
    Eur Psychiatry; 2012 May; 27(4):267-74. PubMed ID: 21036549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and factors associated with metabolic syndrome in an urban population of adults living with HIV in Nairobi, Kenya.
    Kiama CN; Wamicwe JN; Oyugi EO; Obonyo MO; Mungai JG; Roka ZG; Mwangi A
    Pan Afr Med J; 2018; 29():90. PubMed ID: 29875971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial.
    Storch Jakobsen A; Speyer H; Nørgaard HCB; Hjorthøj C; Krogh J; Mors O; Nordentoft M
    Schizophr Res; 2018 Sep; 199():96-102. PubMed ID: 29501386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study.
    Correll CU; Robinson DG; Schooler NR; Brunette MF; Mueser KT; Rosenheck RA; Marcy P; Addington J; Estroff SE; Robinson J; Penn DL; Azrin S; Goldstein A; Severe J; Heinssen R; Kane JM
    JAMA Psychiatry; 2014 Dec; 71(12):1350-63. PubMed ID: 25321337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.